Business Trends– category –
-
Neion Bio Secures $23M Series A to Advance Chicken Egg-Based Biologics API Manufacturing
Endpoints News USA Overview Neion Bio successfully raised $23 million in Series A funding to further develop its innovative technology for producing active pharmaceutical ingredients (APIs) for biologics from chicken eggs. This funding w... -
Kuraray Reaffirms Plans for New U.S. Liquid Rubber Facility to Bolster Global TPE Supply and Sustainable Products
European Rubber Journal Japan Overview Kuraray has reconfirmed its strategic plan to construct a new liquid rubber manufacturing facility in the United States. This investment is integral to the company's isoprene business segment develo... -
ARLANXEO and Covestro Bolster Sustainable Rubber Production Using ISCC PLUS Certified Materials, Advancing Climate Neutrality Goals
MarketScreener Germany Overview ARLANXEO and Covestro are intensifying their collaboration to promote sustainable rubber production by utilizing ISCC PLUS certified mass-balanced raw materials. This partnership aims to reduce reliance on... -
Evonik Initiates Pilot Production of AEM Electrolysis Membranes in Marl, Germany, Targeting 2.5 GW Capacity Annually
Renewables Now Germany Overview Evonik Industries AG has commenced pilot production of high-performance membranes for Anion Exchange Membrane (AEM) electrolysis at its facility in Marl, Germany. The new plant is capable of producing memb... -
Uluu Secures $16M for Marine Degradable PHA Materials, Mitsubishi Chemical and PopSockets Partner on Plant-Derived DURABIO
openPR.com USA Overview Uluu successfully raised $16 million in Series A funding to accelerate the commercialization of marine degradable polyhydroxyalkanoate (PHA) materials. Concurrently, Mitsubishi Chemical Group partnered with PopSoc... -
IBM Invests Over $10 Billion in Quantum Computing: Targeting Fault-Tolerant ‘Quantum Starling’ by 2029 and Building First U.S. Quantum Foundry ‘Anderon’
Futurum Research USA Overview IBM has announced a plan to invest over $10 billion in quantum computing over the next five years, aiming to develop the large-scale, fault-tolerant 'IBM Quantum Starling' by 2029. This investment covers R&a... -
Lipid Nanoparticles vs. Viral Vectors for Gene Delivery: A Comparative Analysis of Advantages and Applications
Pharma Almanac USA Overview This comparative analysis explores the distinct strengths of lipid nanoparticles (LNPs) and viral vectors in gene delivery. While viral vectors like AAV and lentivirus excel in high-efficiency, durable gene ex... -
VIVEbiotech Scales In Vivo Gene Therapy Portfolio to 15 Programs, Securing Key FDA Clinical Trial Approvals
PharmaSource スペイン Overview Spanish CDMO VIVEbiotech has significantly expanded its in vivo lentiviral vector gene therapy portfolio to 15 programs, several of which have already secured regulatory clearance for clinical trials, inclu... -
Century Therapeutics Unveils CNTY-813 iPSC-Derived Islet Replacement Preclinical Data at ADA 2026: Demonstrates Durable Glucose Control, Immune Evasion, and Scalable Manufacturing, IND Filing Expected Q4 2026
BioSpace (via GlobeNewswire) USA Overview Century Therapeutics presented new preclinical data for its iPSC-derived islet replacement therapy, CNTY-813, at the ADA 2026 Scientific Sessions. The data demonstrated durable glucose control, i... -
Preprint Reviews NKG2D CAR-NK Cell Progress in Cancer Immunotherapy: Low GVHD Risk, Scalable Manufacturing, and iPSC-Derived NK Cells as a Platform for Off-the-Shelf Therapies
Preprints.org International Overview A preprint on Preprints.org reviews recent progress in NKG2D CAR-NK cells for cancer immunotherapy, highlighting their favorable safety profile with rare instances of graft-versus-host disease (GVHD) ...
